Wealth Club

The Nasdaq composite led with a 1.5% gain, while the S&P 500 and Dow Jones industrial average rose a respective 1% and 1.2%. Small caps took part in the broad rally as the Russell 2000 advanced 1.4%. Volume was mixed, tracking slightly lower on the NYSE and higher on the Nasdaq, vs. the same time Tuesday.

Big cap techs boosted the tech-heavy Nasdaq. Apple (AAPL) and Microsoft (MSFT) rose nearly 1% each. Apple is trying to climb from its Monday low. The iPhone maker remains 27% off its October peak. Microsoft is approaching a 112.34 buy point of a double-bottom base. The stock is 5% off its highs.

FANG stocks also boosted the Nasdaq. Netflix (NFLX), which boasts the highest renewal rate of U.S. streaming video subscribers, according to a recent report, vaulted 4%. Netflix and Amazon topped TV categories for the Screen Actors Guild Awards nominations, announced Tuesday. Facebook (FB), Amazon (AMZN) and Alphabet (GOOGL) added nearly 2% apiece.

On the Dow, Boeing (BA), Caterpillar (CAT) and DowDuPont (DWDP) rose about 3% each. Verizon (VZ), down nearly 3%, was the biggest loser. It's getting close to testing its 50-day moving average. Morgan Stanley downgraded the telecom giant to equal weight from overweight.

Energy, software and internet retailers were among the biggest sector gainers in the stock market today. Soap makers and utility stocks underperformed.

Among software stocks, Twilio (TWLO) surged 5% to a new high. Three weeks ago, the stock had triggered the 8% loss sell rule after a Nov. 7 breakout failed. The enterprise software maker is featured in today's New America.

Canada Goose (GOOS) led the IBD 50 with a 7% pop in above-average trade, on track to halt a five-session slide. It's trying to hold support at its 50-day line.

Twitter (TWTR) soared more than 5% to pad gains above its 200-day line. Shares have been consolidating after a 21% plunge in late July after the social media company's customer traffic numbers disappointed. They're 22% below a mid-June peak.

IBD 50 medical stocks on the move included biotechs Exelixis (EXEL) and Concept Therapeutrics (CORT), as well as medical services provider BioTelemetry (BEAT). They gained 4%, 3% and 4%, respectively.

The Innovator IBD 50 ETF (FFTY) rose 2% in a bid for its third straight up session.

YOU MIGHT ALSO LIKE:

Track Daily Stock Market Action With The Big Picture

Tesla Stock Hits A Buy Zone As Analyst Notes An Improved Outlook

Twilio Stock Rides Shift To Cloud Computing As New Markets Beckon